Moshe Manor
2019
In 2019, Moshe Manor earned a total compensation of $615.6K as President and Chief Executive Officer at Protalix BioTherapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Option Awards | $39,337 |
|---|---|
| Salary | $362,073 |
| Other | $214,221 |
| Total | $615,631 |
Manor received $362.1K in salary, accounting for 59% of the total pay in 2019.
Manor also received $39.3K in option awards and $214.2K in other compensation.
Rankings
In 2019, Moshe Manor's compensation ranked 11,120th out of 13,971 executives tracked by ExecPay. In other words, Manor earned more than 20.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,120 out of 13,971 | 20th |
Division Manufacturing | 4,500 out of 5,701 | 21st |
Major group Chemicals And Allied Products | 1,766 out of 2,200 | 20th |
Industry group Drugs | 1,520 out of 1,886 | 19th |
Industry Biological Products, Except Diagnostic Substances | 337 out of 389 | 13th |
Source: SEC filing on April 15, 2020.
Manor's colleagues
We found six more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2019.
2019
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2019
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2019
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
2019
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
2019
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2019
Eyal Rubin
Protalix BioTherapeutics